To substantiate the finding of GO-GDC-0973 price induced cell death on erythroid cells, we performed in vivo

exposure of GO in mice. Considerable thrombus formation could be induced by intravenously injected GO, indicating that this method of exposure is not applicable for repeated administration of GO in evaluating its death-inducing effect on blood cells [18, 31]. Thus, selleck inhibitor in the current study, intraperitoneal injection was selected for GO treatment in mice. No mortality in any group was found, and no signs of gross toxic symptoms (such as body weight loss and abnormal activity or diet) were observed (data not shown). The CBC analysis indicated that the RBC number in peripheral blood was reduced by 17% in GO-exposed mice compared to the control mice (Figure 6A, P < 0.05), accompanied by a significant decrease of hemoglobin (HGB) concentration (Figure 6B, P < 0.05) and hematocrit (HCT) (Figure 6C, P < 0.05). These results suggested that GO treatment greatly impaired RBCs, leading to a reduced number in peripheral Ilomastat mouse blood, and also supported the finding of

GO-mediated cell death on erythroid cells (Figure 5). Figure 6 Results of CBC indexes. After a 3-week treatment, mice were sacrificed, and peripheral blood was collected via the heart followed by CBC analysis. (A) Red blood cell (RBC) counts, (B) hemoglobin concentration (HGB), and (C) hematocrit (HCT). (D) After mincing of spleens, the single-cell suspensions were stained with PE conjugated with Ter119+ to label erythroid progenitor population and were then subject to FACS analysis. To validate the effect of GO on the survival of erythroid cells, we further investigated the cell death of erythroid cells from spleen. Since bone marrow and spleen Tolmetin are active sites of erythropoiesis in early course, we looked at the proportion of erythroid cells in spleen

and bone marrow with FACS analysis. As shown in Figure 6D, there was a significant reduction (approximately 10%) of Ter119+ population (representing erythroid cells) in spleens from mice administrated with GO compared to the control (P < 0.05), indicating that GO exposure diminished erythroid cells in spleen. To substantiate this observation, we assessed the cell death of Ter119+ cells by simultaneously staining the splenic cells with PE-conjugated anti-Ter119 Ab, FITC-conjugated Annexin V, and 7AAD [30]. Similar to PI, 7AAD was used to label necrotic dead cells. Under the FACS analysis, Ter119+ cells were selected for the determination of cell death with Annexin V and 7AAD (Figure 7). Compared to the control mice, there was a significant increase in the percentage of apoptotic Ter119+ cells in spleens from the GO-exposed mice (Figure 7, P < 0.05).